PHIO Insider Trading Activity and SEC Form 4 Filings
PHIO insider trading summary
Over the past 12 months, insiders at Phio Pharmaceuticals Corp. (PHIO) reported 11 open-market purchases worth $86K by 3 insiders and no sales on SEC Form 4. Net insider buying was $86K.
Latest PHIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Ronald Todd Plott | Director | Buy | $5K (5,000 @ $1.04) |
| Sep 28, 2026 | Ronald Todd Plott | Director | Buy | $5K (5,000 @ $1.03) |
| Sep 24, 2026 | Patricia A Bradford | Director | Buy | $7K (6,500 @ $1.01) |
| Sep 22, 2026 | Robert J Bitterman | Chairman, Pres. & CEO | Buy | $2K (2,000 @ $1.03) |
| Sep 15, 2026 | Patricia A Bradford | Director | Buy | $12K (12,000 @ $1.03) |
| Aug 19, 2026 | Ronald Todd Plott | Director | Buy | $17K (15,000 @ $1.14) |
| Aug 18, 2026 | Robert J Bitterman | Chairman, Pres. & CEO | Buy | $11K (10,000 @ $1.06) |
| Jun 26, 2026 | Robert J Bitterman | Chairman, Pres. & CEO | Buy | $10K (10,000 @ $0.99) |
| Dec 31, 2025 | Robert J Bitterman | Chairman, Pres. & CEO | Buy | $5K (5,000 @ $1.03) |
| Nov 21, 2025 | Robert J Bitterman | Chairman, Pres. & CEO | Buy | $6K (5,000 @ $1.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.